Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 12/31/2019

Month EndAs of 12/31/2019 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 35.19 10.80 3.62 16.23 11.26
Fund with Sales Charge (%) (POP) 35.19 10.80 3.62 16.23 11.26
NASDAQ Biotechnology Index (%) 24.41 10.95 3.57 16.34 11.70
S&P 500 Index (%) 31.49 15.28 11.70 13.56 7.81
Quarter EndAs of 12/31/2019 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 35.19 10.80 3.62 16.23 11.26
Fund with Sales Charge (%) (POP) 35.19 10.80 3.62 16.23 11.26
NASDAQ Biotechnology Index (%) 24.41 10.95 3.57 16.34 11.70
S&P 500 Index (%) 31.49 15.28 11.70 13.56 7.81

Calendar Year Returns

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund without Sales Charge (%) (NAV) 35.19 -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65 17.64
Fund with Sales Charge (%) (POP) 35.19 -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65 17.64
NASDAQ Biotechnology Index (%) 24.41 -9.32 21.06 -21.68 11.42 34.32 65.97 32.29 12.08 15.25
S&P 500 Index (%) 31.49 -4.38 21.83 11.96 1.38 13.69 32.39 16.00 2.11 15.06

Cumulative Total Returns [further-information] As of 12/31/2019

Month EndAs of 12/31/2019 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 35.19 35.19 36.04 19.46 349.93 979.29
Fund with Sales Charge (%) (POP) 35.19 35.19 36.04 19.46 349.93 979.29
NASDAQ Biotechnology Index (%) 24.41 24.41 36.56 19.17 353.96 1,077.15
S&P 500 Index (%) 31.49 31.49 53.17 73.86 256.66 434.87
Quarter EndAs of 12/31/2019 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 35.19 35.19 36.04 19.46 349.93 979.29
Fund with Sales Charge (%) (POP) 35.19 35.19 36.04 19.46 349.93 979.29
NASDAQ Biotechnology Index (%) 24.41 24.41 36.56 19.17 353.96 1,077.15
S&P 500 Index (%) 31.49 31.49 53.17 73.86 256.66 434.87

After-Tax Average Annual Total Returns [further-information] As of 12/31/2019

No chart available for this data.
Month EndAs of 12/31/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold
Fund without Sales Charge (%) (NAV) After Shares Sold
Fund with Sales Charge (%) (POP) Before Shares Sold
Fund with Sales Charge (%) (POP) After Shares Sold
No chart available for this data.
Quarter EndAs of 12/31/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold
Fund without Sales Charge (%) (NAV) After Shares Sold
Fund with Sales Charge (%) (POP) Before Shares Sold
Fund with Sales Charge (%) (POP) After Shares Sold

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 0.79%
Net Expense Ratio [further-information] 0.77%
Max Initial Sales Charge 0.00%
CDSC

Volatility Measures [further-information] As of 12/31/2019 Updated Monthly, based on a 3-year period

Beta 1.05
Sharpe Ratio 0.41
Standard Deviation 22.49

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index